Current determination of the histological type of prostate cancer by invasive clinical diagnostic procedures, e.g., biopsy, may only be achieved several years after the initial finding of elevated levels of prostate-specific antigen (PSA) due to limitations of existing imaging methodologies for non-invasive assessment of the tumor. This evidence concerns the gene KLK3 and neoplasm.